When did SUTRO BIOPHARMA INC (STRO) report earnings last quarter?
SUTRO BIOPHARMA INC (STRO) last reported earnings on 3/11/2026.
SUTRO BIOPHARMA INC (STRO) Earnings History & Surprises
NASDAQ:STRO • US8693672011
Current stock price
21.33 USD
+0.65 (+3.14%)
At close:
21.33 USD
0 (0%)
After Hours:
STRO Earnings overview
Past quarterly earnings results for SUTRO BIOPHARMA INC (STRO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 6, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$4.43
- Revenue Estimate
- 8.508M
Last Reported
Most Recent- Release Date
- Mar 11, 2026
- Period
- Q3 / 2025
- EPS Reported
- -$6.70
- EPS Surprise
- -58.49%
- Revenue Surprise
- 4.07%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -6.70 | -4.23 | -58.49% | -13.56% | 9.693M | 9.314M | 4.07% | 13.77% |
| Q2 2025 | -1.40 | -4.10 | 65.88% | 76.27% | 63.745M | 14.538M | 338.47% | 147.98% |
| Q1 2025 | -9.10 | -7.22 | -26.10% | 4.21% | 17.399M | 11.843M | 46.91% | 33.76% |
| Q4 2024 | -8.90 | -8.48 | -4.99% | -271.15% | 14.809M | 12.685M | 16.74% | -86.98% |
| Q3 2024 | -5.90 | -7.49 | 21.27% | 27.16% | 8.52M | 15.558M | -45.24% | -49.66% |
| Q2 2024 | -5.90 | -8.08 | 26.97% | 7.81% | 25.706M | 21.441M | 19.89% | 146.89% |
| Q1 2024 | -9.50 | -9.40 | -1.02% | -11.76% | 13.008M | 12.312M | 5.65% | 2.64% |
| Q4 2023 | 5.20 | -8.40 | 161.92% | 176.47% | 113.721M | 12.044M | 844.21% | 1,217.74% |
| Q3 2023 | -8.10 | -7.51 | -7.90% | -118.92% | 16.924M | 13.259M | 27.64% | -32.71% |
| Q2 2023 | -6.40 | -7.47 | 14.34% | -16.36% | 10.412M | 12.808M | -18.71% | -62.95% |
| Q1 2023 | -8.50 | -8.28 | -2.70% | -1.19% | 12.674M | 11.373M | 11.44% | 114.81% |
| Q4 2022 | -6.80 | -6.34 | -7.31% | 18.07% | 8.63M | 14.768M | -41.56% | -18.97% |
| Q3 2022 | -3.70 | -7.53 | 50.87% | 44.78% | 25.15M | 12.932M | 94.48% | 195.19% |
| Q2 2022 | -5.50 | -4.71 | -16.86% | -323.08% | 28.1M | 17.021M | 65.09% | 0.18% |
| Q1 2022 | -8.40 | -7.73 | -8.72% | -27.27% | 5.9M | 10.675M | -44.73% | -59.75% |
| Q4 2021 | -8.30 | -7.03 | -18.15% | 43.92% | 10.65M | 10.865M | -1.98% | 28.62% |
| Q3 2021 | -6.70 | -6.64 | -0.86% | -248.89% | 8.52M | 9.148M | -6.86% | -52.19% |
| Q2 2021 | -1.30 | -4.22 | 69.20% | 77.97% | 28.05M | 13.605M | 106.17% | 196.20% |
| Q1 2021 | -6.60 | -6.15 | -7.28% | 21.43% | 14.66M | 5.843M | 150.90% | 105.03% |
| Q4 2020 | -14.80 | -5.81 | -154.56% | - | 8.28M | 9.575M | -13.52% | - |
| Q3 2020 | 4.50 | -5.17 | 186.99% | - | 17.82M | 8.67M | 105.54% | - |
| Q2 2020 | -5.90 | -6.57 | 10.15% | - | 9.47M | 8.128M | 16.51% | - |
| Q1 2020 | -8.40 | -7.02 | -19.60% | - | 7.15M | 10.909M | -34.46% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-5.93%
Max EPS beat (4)
65.88%
Min EPS beat (4)
-58.49%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
101.55%
Max Revenue beat (4)
338.47%
Min Revenue beat (4)
4.07%
Analysis
In the last 4 quarters, STRO has beaten EPS estimates in 1 out of 4 releases
STRO has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, STRO reported -5.9% below the EPS estimates on average.
In the last 4 quarters, STRO has beaten the revenue estimates by 101.5% on average.
Related analysis
SUTRO BIOPHARMA INC / STRO Earnings FAQ
Did STRO stock beat earnings estimates in the most recent quarter?
SUTRO BIOPHARMA INC (STRO) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often SUTRO BIOPHARMA INC beats earnings estimates?
In the last 4 quarters, SUTRO BIOPHARMA INC (STRO) has beaten EPS estimates in 1 out of 4 releases.